Xanax Statistics

Xanax is among America's most-prescribed and most-misused medicines, and benzodiazepines trail only opioids in prescription-overdose deaths. Here's what the numbers say about who's affected, why the mixes turn deadly, and why recovery is the rule.

Jessica Miller is the Content Manager of Addiction HelpWritten by
Kent S. Hoffman, D.O. is a founder of Addiction HelpMedically reviewed by Kent S. Hoffman, D.O.
Last updated

Battling addiction & ready for help?

Find Treatment Now

Xanax by the Numbers

Behind every figure here is a person, so start with the one that matters most: Xanax (alprazolam) is one of the central-nervous-system depressants most often named in fatal overdoses, almost always alongside another drug[1]. The numbers can read as alarming, and they are meant to be taken seriously, but they describe a problem that is recognized, treatable, and survivable. People get free of Xanax every day, and the data on how harm happens is exactly what helps you stay on the safe side of it.

A note on what these numbers are. Most national datasets count benzodiazepines as a class rather than alprazolam by name, and many of the large studies below pool sedatives and tranquilizers together. So some figures describe the whole benzodiazepine family with Xanax as a leading member, not Xanax alone, and that is flagged where it matters.

Getting off Xanax safely starts with a supervised taper. Call 988 if you're in danger.
If you’re in danger right now or thinking about suicide, call or text 988 (Suicide & Crisis Lifeline), any time.

What to do:

  • Get into a medically supervised taper or detox — a slow, planned dose reduction is the safe way off Xanax, and it makes withdrawal far easier than stopping on your own. Find a Xanax detox or taper →
  • Until then, keep taking Xanax exactly as prescribed and never combine it with opioids or alcohol — the worst outcomes come from stopping suddenly or mixing, and both are avoidable[1].
  • If someone mixed Xanax with opioids or alcohol and won’t wake up, call 911. Naloxone reverses opioids but not Xanax — give it anyway if opioids may be involved, then call 911.

Find treatment today →

AddictionHelp.com Fast Facts
  • Xanax is one of the depressants most often found in fatal overdoses, and those deaths almost always involve more than one drug taken together[1].
  • After opioids, benzodiazepines are the medication class most commonly involved in prescription overdoses in the United States[2].
  • Benzodiazepines are among the most commonly used and misused controlled medications, and alprazolam is a leading example studied for misuse[3][4].
  • The danger is concentrated in two places — stopping suddenly and mixing — and both are avoidable with a supervised taper and by never combining Xanax with opioids or alcohol[1].

Xanax Addiction Statistics

The clearest way to read the Xanax numbers is to separate three things: how widely it’s prescribed, how often it’s misused, and how the harm actually lands. The headline is plain: benzodiazepines, with alprazolam among the most prominent, sit near the center of the prescription-drug problem in the United States.

Benzodiazepines Are Among the Most Misused Controlled Medicines

National research is blunt about where benzodiazepines rank. They are among the most commonly used and misused controlled medications in the country[3]. When studies of prescription tranquilizer and sedative misuse name the drugs people misuse, alprazolam is listed first as the prototype example[4]. And reviews of the whole class describe rising rates of misuse, dependence, and overdose, a concern that climbs sharply when these drugs are combined with opioids[5].

The scale of the studies tracking this is itself telling. Researchers have followed misuse across enormous nationally representative samples:

Dataset behind the numbers Sample size What it tracked
National Survey on Drug Use and Health, 2015-16 114,043 people[4] Tranquilizer/sedative use and misuse across US age cohorts
National Survey on Drug Use and Health, 2021-23 139,524 adults[6] Past-month prescription tranquilizer misuse
National cohorts of US 12th graders 26,575 people[3] Benzodiazepine use to misuse, followed from age 18 to 50
Older adults, national epidemiologic survey 14,667 adults 50+[7] Prescription drug misuse by medication class

These are not small studies or one-off surveys. Tens of thousands of Americans are sampled in each, which is why the finding that benzodiazepines rank near the top of misused controlled medicines carries weight rather than noise.

Misuse Usually Starts with a Real Prescription

A persistent myth is that benzodiazepine trouble begins on the street. The research points the other way, and it matters because it changes who needs to pay attention. Studies follow people who transition from medical use of prescription benzodiazepines into misuse, and from there into opioid misuse and broader substance-use-disorder symptoms over the course of adulthood[3]. The pill bottle, not the dealer, is where it tends to start.

How misuse looks in practice has a recognizable shape. With sedatives like alprazolam, misuse is often self-medication that escalates — taking a little more than directed, then requesting early refills as the dose creeps up[8]. That pattern is why “I was only taking what I was prescribed” and “I ended up dependent” so often describe the same person.

Older Adults Are a Quietly High-Risk Group

The stereotype of benzodiazepine misuse is young and recreational, but a large share of the risk sits at the other end of life. Chronic use of benzodiazepine-type drugs remains common among adults aged 65 and older, despite long-standing concerns about falls, cognitive impairment, and functional decline[9]. Older-adult misuse is understudied even though it carries serious consequences, which is why researchers have worked to map where older people get the medication in the first place[10].

Did you know?

The danger older adults face shows up in the emergency room. Older adults already account for an estimated 15% to 25% of all US emergency department visits, and they are admitted to the hospital from the ED at far higher rates than younger patients — roughly 35% to 45% of the time. About 10% of those older-adult ED visits are medication-related[11]. Benzodiazepines like Xanax, with their links to falls and confusion, are part of why a medicine meant to calm can land an older person in a hospital bed.

Xanax Abuse Statistics

Knowing who is most likely to misuse Xanax, and how, is what turns a wall of numbers into something useful. The patterns are consistent across studies: misuse clusters in particular groups, it rarely happens with a single drug, and the prescribing that feeds it has its own measurable trends.

Who Misuses Xanax

No single group owns this problem, but the research has surfaced clear correlates. Misuse of prescription tranquilizers and sedatives, the category alprazolam leads, has been mapped across every adult age cohort in the United States[4]. Some groups carry a heavier load: a nationally representative analysis found higher prescription tranquilizer misuse among bisexual adults than the general population[6]. And among older adults, misuse travels with poor mental-health and quality-of-life outcomes, which is part of why poly-misuse in people over 50 is treated as its own concern[7].

Xanax Is Rarely Misused Alone

What 'polysubstance' meansPolysubstance simply means more than one drug in the body at the same time. It’s the medical way of describing a mix, and with depressants like Xanax the mix is what turns a survivable situation dangerous.

This is the single most important pattern in the abuse data, because it’s the one that kills. Polysubstance use is the norm, not the exception — and it’s getting more common. Polysubstance involvement is increasing among fatal drug overdoses, and benzodiazepines are repeatedly among the substances found in those deaths alongside opioids, stimulants, and alcohol[12]. Large emergency-department studies of suspected overdoses were built specifically because drugs used in combination drive both nonfatal and fatal overdose risk[13].

Overdose surveillance study Scale Window
CDC-funded ED overdose surveillance, 18 states 120,706 ED visits[13] 2017-2018
Prescription-depressant overdose deaths, Massachusetts 8,665 decedents[14] 2000-2023
US overdose-death trends, National Vital Statistics 9 drug categories tracked[15] 1999-2022

The combination that recurs in the literature is benzodiazepines with opioids. Overlapping opioid and benzodiazepine prescriptions are associated with increased overdose risk, and that risk is higher still when the prescriptions come from multiple prescribers rather than one[16]. The danger of mixing isn’t a fringe scenario — it’s the main event.

Benzodiazepine Prescribing Has Its Own Trends

Misuse tracks supply, and supply is measurable. National researchers have analyzed benzodiazepine prescribing trends from US emergency departments across 2012 to 2019 to understand where the drugs enter circulation[17]. Internationally, the prescribing picture is similar enough to draw concern: in one national analysis, more than half of hypnotic and anxiolytic prescriptions were written by physicians rather than specialists, with long-term benzodiazepine use persisting despite guidelines that recommend only a few weeks[18].

The policy response has produced its own data point. Prescription drug monitoring programs, the state databases that flag risky prescribing, have been studied for their effect on the young: mandated-review programs are associated with reduced benzodiazepine dispensing and overdose among adolescents and young adults[19]. The lever works, which is itself evidence that prescribing drives the harm.

How Xanax Compares Within the Benzodiazepine Family

Xanax rarely shows up alone in the data, and it rarely shows up apart from its drug family. Reading the class-level numbers is the only way to see where alprazolam sits, because that’s how most surveillance systems count.

Xanax Is a Leading Member of a Heavily Used Class

When researchers list the prescription drugs with the greatest potential for misuse, benzodiazepines sit among the top categories alongside opioids, gabapentinoids, Z-drugs, and stimulants[20]. Within that family, alprazolam is singled out repeatedly: it’s the first-named example when studies define prescription tranquilizer and sedative misuse[4], and the class as a whole is flagged for rising misuse, dependence, and overdose[5]. Xanax isn’t an outlier in a safe class — it’s a prominent member of a class under scrutiny.

Benzodiazepines Travel with Opioid Treatment, Too

One overlooked corner of the data is opioid treatment. Benzodiazepine co-use is common among patients in opioid agonist treatment and has been linked to increased mortality[21]. It’s a reminder that the Xanax-and-opioid overlap isn’t confined to recreational misuse — it reaches into clinical populations, which is why clinicians watch benzodiazepine use so closely when opioids are also in the picture.

Xanax Overdose and Emergency Data

This is where the numbers get serious, and where the central truth of Xanax statistics lives: taken alone, alprazolam is comparatively forgiving, but the deaths come from combination. Almost every figure here points back to the same lesson.

Benzodiazepines Rank Second Only to Opioids in Prescription Overdoses

The ranking is stark. After opioids, benzodiazepines are the medication most commonly involved in prescription overdoses in the United States[2]. That finding comes from work using a 20% sample of all Medicare beneficiaries with prescription drug coverage, a dataset large enough to make the second-place ranking solid rather than suggestive[2].

Zoom out to the whole class and the framing is the same: benzodiazepines have become a public-health concern precisely because of rising rates of misuse, dependence, and overdose, particularly when co-administered with opioids[5].

The Deaths Are About Polydrug Combinations

The overdose literature keeps arriving at one conclusion. Alprazolam is among the CNS depressants most often implicated in fatal overdose, with a high share of deaths involving polydrug interactions — frequently from the person’s own prescriptions[1]. When researchers built a 23-year cohort of prescription-depressant overdose deaths in Massachusetts, the entire purpose was to untangle which substances were co-involved, because a depressant rarely kills alone[14].

The mechanics behind the statistic are simple and worth holding onto:

  • Xanax plus opioids — heroin, fentanyl, or prescription painkillers. Overlapping benzodiazepine-and-opioid prescriptions are a documented overdose-risk driver, especially across multiple prescribers[16].
  • Xanax plus alcohol — two nervous-system depressants stacked, deepening the risk of slowed or stopped breathing.
  • Xanax in a polysubstance mix — the increasingly common pattern in fatal overdoses, where benzodiazepines turn up alongside several other drugs[12].

Overdose Deaths Are Climbing, and the Pattern Is Shifting

The broader overdose trend gives the Xanax numbers their urgency. Tracking US overdose deaths from 1999 through 2022 across nine drug categories, researchers found that unintentional overdoses involving synthetic opioids and polydrug toxicity rose exponentially, with annual percentage increases ranging from 15.0% to 104.9% depending on the category[15]. Benzodiazepines like Xanax live inside that polydrug story — not usually the sole cause on a death certificate, but a frequent passenger in the combinations that are rising fastest.

Xanax in the Counterfeit Pill Era

The single biggest change in the Xanax risk picture isn’t in a prescribing database — it’s in what a street “Xanax” pill now contains. The data here is less about clean percentages and more about a documented, dangerous shift.

Counterfeit “Xanax” Often Isn’t Xanax

Counterfeit vs. contaminatedA counterfeit pill is pressed to look like real Xanax but made illicitly, so you can’t know what’s actually in it. Contaminated means another substance has been mixed in. Either way, a pill from outside a pharmacy is an unknown.

Researchers studying prescription-drug misuse now define it to include illicitly sourced pills that may be counterfeit or contaminated, a deliberate broadening of the term that reflects today’s supply[20]. The illicit market presses tablets to look identical to real Xanax bars while containing something else entirely — unknown designer benzodiazepines, or fentanyl. The proactive-toxicology literature is explicit that alprazolam and fentanyl together are a major driver of fatal overdose, which is exactly the combination a pressed counterfeit can deliver in a single pill[1].

The practical statistic is one you can’t put a clean percentage on but can’t afford to ignore: a tablet bought outside a pharmacy may look exactly like a prescription Xanax bar and be nothing of the kind. If it didn’t come from a pharmacy, its contents are unknown.

Why the Mixing Risk Keeps Growing

Two forces push the same direction:

  • More mixing — polysubstance involvement in fatal overdoses is rising as a documented trend[12].
  • More unknowns — the prescription-drug-misuse field has formally folded counterfeit and contaminated pills into its definition of the problem[20].

Put together, the modern Xanax danger isn’t only the drug — it’s the unknown drug standing in for it.

What Raises the Risk of Xanax Harm

The data doesn’t just count harm — it points to what makes it more likely. A handful of risk factors recur across studies, and each one is something you or a clinician can actually act on.

Co-Prescribing Is a Measurable Risk Multiplier

The most consistent risk signal in the literature is overlap with opioids. Receiving overlapping opioid and benzodiazepine prescriptions is associated with increased overdose risk, and that risk rises further when the prescriptions are written by multiple prescribers rather than coordinated by one[16]. This is the danger the FDA’s black-box warning on combined opioid-and-benzodiazepine use is built to address[22].

Age and Prescribing Patterns Shape the Risk

Two structural factors keep surfacing:

  • Age — older adults are a high-use, high-consequence group, with chronic benzodiazepine-type use common past 65 despite the falls and cognitive risks[9], and with medication-related problems behind roughly 10% of older-adult ED visits[11].
  • Length of use — long-term benzodiazepine prescribing persists even where guidelines recommend only a few weeks of use[18].

Long courses and stacked prescriptions are where the measurable danger concentrates.

Dependence and Treatment Statistics

Here is the part of the data that fear tends to hide: dependence is common, but recovery is the expected outcome with proper care. The numbers on treatment are, on balance, hopeful.

Dependence Is Common and Often Begins with Doctor-Prescribed Use

Dependence isn't the same as addictionPhysical dependence is the body adapting to a medicine taken as directed, so stopping needs a plan. Addiction is the loss of control over using it. Many people who become dependent never lose that control, and either way it isn’t a moral failing.

The treatment literature consistently distinguishes physical dependence — an expected adaptation of the body — from addiction. What the data adds is that the road in often runs through legitimate prescriptions: studies trace people moving from medical benzodiazepine use into misuse and dependence[3], and the pattern of dose escalation and early-refill requests is how clinicians spot it[8]. None of that is a character flaw. It’s a predictable response to a drug the nervous system adapts to.

Stopping Is Safe and Effective When It’s Done Gradually

The encouraging counterweight is that getting off benzodiazepines has a real evidence base. Reviews of how to come off these drugs have catalogued the strategies in detail — one scoping review alone identified 39 original research studies and 26 clinical guidelines on deprescribing opioids and benzodiazepines[22]. The core principle that emerges is a gradual, structured taper, and for older adults in particular, researchers have worked to confirm which structured deprescribing approaches are both safe and effective[9].

What the treatment data supports Source
A gradual, structured taper is the proven core of stopping [22]
Structured deprescribing can be done safely, including in older adults [9]
Prescription monitoring reduces risky dispensing and overdose in the young [19]
Misuse is identifiable early through dose escalation and early refills [8]

The takeaway from the treatment numbers is steadying: this is a well-studied problem with a well-understood way out. The danger is in stopping suddenly or mixing — not in stopping the right way.

Getting Help for Xanax Addiction

Every figure above is, in the end, a person — someone prescribed a pill for panic who didn’t expect it to take over, someone who lost a night to a combination they didn’t know was deadly, someone wondering if they’ve gone too far to come back. You haven’t.

The statistics that matter most are the hopeful ones. Dependence on Xanax is common and treatable. The proven path off is a slow, supervised taper paired with support, and it works[22][9]. The two things that drive the frightening numbers — stopping cold turkey and mixing Xanax with opioids or alcohol — are exactly the two things a treatment team helps you avoid[1]. Recovery is not the exception in these numbers. With proper care, it’s the expectation.

To go deeper, learn how to recognize the problem in Xanax addiction signs and symptoms, see how the wider drug family compares in benzodiazepine statistics, and read about the whole class in benzodiazepines.

If any of this lands, the next step doesn’t have to be a big one. Our treatment centers directory can point you to the right level of care. Reaching out today is a real step forward — and one you can make right now.

Frequently asked questions

How common is Xanax misuse?

Benzodiazepines, the family Xanax belongs to, are among the most commonly used and misused controlled medications in the United States, and alprazolam is repeatedly singled out as a leading example when researchers define prescription tranquilizer and sedative misuse[3][4]. The studies behind that finding are large: national surveys tracking tranquilizer misuse have sampled 114,043 people in one wave and 139,524 adults in another[4][6]. One important note on the numbers is that most national datasets count benzodiazepines as a class rather than alprazolam by name, so the precise share of misuse that is Xanax specifically is hard to isolate, even though it is one of the most prominent drugs in that class.

How dangerous is a Xanax overdose?

Taken alone, alprazolam is comparatively forgiving, but the danger climbs sharply in combination, and that is where the deaths are. Alprazolam is one of the central-nervous-system depressants most often implicated in fatal overdose, and those deaths overwhelmingly involve more than one drug taken together[1]. After opioids, benzodiazepines are the medication class most commonly involved in prescription overdoses in the US[2]. If someone is unresponsive or breathing slowly, call 911. Naloxone (Narcan) can reverse the opioid part of a mixed overdose, so give it if opioids may be involved, but it does not reverse Xanax, so call 911 regardless.

What drugs are most often mixed with Xanax in overdoses?

Opioids and alcohol are the combinations that turn dangerous, and polysubstance use is the rule rather than the exception. Polysubstance involvement is increasing among fatal drug overdoses, with benzodiazepines repeatedly found alongside opioids, stimulants, and alcohol[12]. The opioid overlap is especially well documented: receiving overlapping opioid and benzodiazepine prescriptions is associated with increased overdose risk, and that risk is higher still when the prescriptions come from multiple prescribers[16]. Large emergency-department studies of overdoses, one covering 120,706 ED visits across 18 states, were built specifically because drugs used in combination drive the risk[13].

Who is most at risk of misusing Xanax?

Misuse has been mapped across every adult age cohort in the United States, so no single group owns it[4]. That said, the research points to several higher-risk patterns. A nationally representative analysis found higher prescription tranquilizer misuse among bisexual adults than the general population[6]. Older adults are a quietly high-risk group, with chronic benzodiazepine-type use common past age 65 despite the risks of falls and confusion[9]. And misuse often begins not on the street but with a real prescription, as people transition from medical use into misuse over time[3].

Are counterfeit Xanax pills a real statistical danger?

Yes, and it is the biggest recent shift in the Xanax risk picture. The prescription-drug-misuse field has formally broadened its definition of the problem to include illicitly sourced pills that may be counterfeit or contaminated, which reflects today’s supply[20]. The specific danger is that pressed tablets made to look identical to real Xanax bars can contain unknown designer benzodiazepines or fentanyl, and alprazolam combined with fentanyl is a major driver of fatal overdose[1]. The practical point you cannot put a clean percentage on but cannot afford to ignore: a pill bought outside a pharmacy may look exactly like a prescription Xanax bar and be nothing of the kind.

Can people recover from Xanax dependence?

Yes, recovery is the expected outcome with proper care, and that is the most important statistic of all. Getting off benzodiazepines has a real evidence base. One scoping review alone catalogued 39 original research studies and 26 clinical guidelines on deprescribing opioids and benzodiazepines, and the core principle that emerges is a gradual, structured taper[22]. Structured deprescribing has been studied for safety and effectiveness, including in older adults[9]. The two things that drive the frightening overdose numbers, stopping suddenly and mixing with other depressants, are exactly the two things a treatment team helps you avoid. You can find treatment and people who can help at /find-treatment-help/.

Get Treatment Help

If you or someone you love is struggling with addiction, getting help is just a phone call away, or consider trying therapy online with BetterHelp.

Exclusive offer: 20% Off BetterHelp*

Following links to the BetterHelp website may earn us a commission that helps us manage and maintain AddictionHelp.com. *Get 20% off your first month of BetterHelp. Offer valid for new BetterHelp users only. Offer cannot be combined with insurance.

22 Sources
  1. Carry E, Vasilatis A, Johnson AL, Ryan JW (2025). Expecting medication misuse: a proactive approach to drug discovery to prevent fatal overdose. Future medicinal chemistry. https://doi.org/10.1080/17568919.2025.2476388
  2. Maust DT, Bohnert ASB, Strominger J, Goldstick JE (2023). Prescription characteristics associated with drug overdose risk among adults prescribed benzodiazepines: a cohort study. BMC pharmacology & toxicology. https://doi.org/10.1186/s40360-023-00674-x
  3. McCabe SE, Schulenberg JE, Wilens TE, Schepis TS, McCabe VV, Veliz P (2023). Transitions in Prescription Benzodiazepine Use and Misuse and in Substance Use Disorder Symptoms Through Age 50. Psychiatric services (Washington, D.C.). https://doi.org/10.1176/appi.ps.20220247
  4. Schepis TS, Teter CJ, Simoni-Wastila L, McCabe SE (2018). Prescription tranquilizer/sedative misuse prevalence and correlates across age cohorts in the US. Addictive behaviors. https://doi.org/10.1016/j.addbeh.2018.06.013
  5. Figg JW, Love CA, Sorathia V, Engelbart M, Turner A, Elton A (2026). Benzodiazepines at the crossroads: navigating therapeutic promise and perils of misuse. Annals of general psychiatry. https://doi.org/10.1186/s12991-025-00627-0
  6. Lee J, Ahlquist J, Parker M (2025). Higher Prescription Tranquilizer Misuse Among Bisexual Individuals in the United States, 2021-2023. Substance use & misuse. https://doi.org/10.1080/10826084.2025.2491771
  7. Schepis TS, Ford JA, Wastila L, McCabe SE (2021). Opioid-involved prescription drug misuse and poly-prescription drug misuse in U.S. older adults. Aging & mental health. https://doi.org/10.1080/13607863.2020.1839859
  8. Weaver MF (2015). Prescription Sedative Misuse and Abuse. The Yale journal of biology and medicine.
  9. O'Hara-Veintimilla K, Páez-García S, Ramirez-Triana J, Torres-Tello K, Verhelst-Forero P, Borda Borda MG (2026). Safety and effectiveness of strategies to deprescribe chronic benzodiazepine receptor agonist use in older adults: a systematic review. Age and ageing. https://doi.org/10.1093/ageing/afag112
  10. Schepis TS, McCabe SE (2019). Prescription Tranquilizer/Sedative Sources for Misuse in Older Adults. Substance use & misuse. https://doi.org/10.1080/10826084.2019.1613434
  11. Metts E, Carroll S, Posen A, Rech MA, Weant K (2026). Medication Safety Strategies for Geriatric Patients in the Emergency Department: A Narrative Review. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine. https://doi.org/10.1111/acem.70325
  12. Figgatt MC, Austin AE, Cox ME, Proescholdbell S, Marshall SW, Naumann RB (2021). Trends in unintentional polysubstance overdose deaths and individual and community correlates of polysubstance overdose, North Carolina, 2009-2018. Drug and alcohol dependence. https://doi.org/10.1016/j.drugalcdep.2020.108504
  13. Liu S, Vivolo-Kantor A (2020). A latent class analysis of drug and substance use patterns among patients treated in emergency departments for suspected drug overdose. Addictive behaviors. https://doi.org/10.1016/j.addbeh.2019.106142
  14. Lee H, Dong H, Jalali MS, Stringfellow EJ (2026). Prescription Depressant-Involved Overdose Mortality in Massachusetts (2000-2023): A Cohort Study. Journal of general internal medicine. https://doi.org/10.1007/s11606-025-10113-8
  15. Nguyen A, Wang J, Holland KM, Ehlman DC, Welder LE, Miller KD, et al. (2024). Trends in Drug Overdose Deaths by Intent and Drug Categories, United States, 1999‒2022. American journal of public health. https://doi.org/10.2105/ajph.2024.307745
  16. Chua K, Brummett CM, Ng S, Bohnert ASB (2021). Association Between Receipt of Overlapping Opioid and Benzodiazepine Prescriptions From Multiple Prescribers and Overdose Risk. JAMA network open. https://doi.org/10.1001/jamanetworkopen.2021.20353
  17. Ramdin C, Mina G, Nelson L, Mazer-Amirshahi M (2024). Benzodiazepine Discharge Prescriptions From Emergency Departments Across the United States Between 2012 and 2019: A National Analysis. Journal of addiction medicine. https://doi.org/10.1097/adm.0000000000001310
  18. Hirooka T (2015). [Excessive prescribing of hypnotic and anxiolytic drugs in Japan]. Nihon rinsho. Japanese journal of clinical medicine.
  19. Toce MS, Michelson KA, Hudgins JD, Olson KL, Monuteaux MC, Bourgeois FT (2023). Association of prescription drug monitoring programs with benzodiazepine prescription dispensation and overdose in adolescents and young adults. Clinical toxicology (Philadelphia, Pa.). https://doi.org/10.1080/15563650.2023.2181092
  20. Cousins G, Durand L, O'Kane A, Tierney J, Maguire R, Stokes S, et al. (2023). Prescription drugs with potential for misuse: protocol for a multi-indicator analysis of supply, detection and the associated health burden in Ireland between 2010 and 2020. BMJ open. https://doi.org/10.1136/bmjopen-2022-069665
  21. Hestevik CH, Evensen LH, Kornør H, Skeie I (2024). The association between benzodiazepine co-prescription, opioid agonist treatment and mortality: a systematic review. BMC psychiatry. https://doi.org/10.1186/s12888-024-06191-3
  22. Wang Y, Wilson DL, Fernandes D, Adkins LE, Bantad A, Copacia C, et al. (2023). Deprescribing Strategies for Opioids and Benzodiazepines with Emphasis on Concurrent Use: A Scoping Review. Journal of clinical medicine. https://doi.org/10.3390/jcm12051788
Written by
Jessica Miller is the Content Manager of Addiction Help

Editorial Director

Jessica Miller is the Editorial Director of Addiction Help. Jessica graduated from the University of South Florida (USF) with an English degree and combines her writing expertise and passion for helping others to deliver reliable information to those impacted by addiction. Informed by her personal journey to recovery and support of loved ones in sobriety, Jessica's empathetic and authentic approach resonates deeply with the Addiction Help community.

Reviewed by
  • Fact-Checked
  • Editor
Kent S. Hoffman, D.O. is a founder of Addiction Help

Co-Founder & Chief Medical Officer

Kent S. Hoffman, D.O. has been an expert in addiction medicine for more than 15 years. In addition to managing a successful family medical practice, Dr. Hoffman is board certified in addiction medicine by the American Osteopathic Academy of Addiction Medicine (AOAAM). Dr. Hoffman has successfully treated hundreds of patients battling addiction. Dr. Hoffman is the Co-Founder and Chief Medical Officer of AddictionHelp.com and ensures the website’s medical content and messaging quality.

Real Help. Real Recovery.

Compare centers, explore options and start your path to recovery today.

Find Treatment Now

"AddictionHelp.com is helping to make recovery available to EVERYONE!"

- Angela N.